Supernus Pharm (SUPN) Posts Q3 Loss of 55c/Share

Supernus Pharm (NASDAQ: SUPN) reported Q3 EPS of ($0.55), $0.07 better than the analyst estimate of ($0.62).

For earnings history and earnings-related data on Supernus Pharm (SUPN) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Oracle reports earnings today: AI spending bet faces its toughest test yet
• Academy Sports & Outdoors Inc. (ASO) PT Raised to $47 at BMO Capital
• Diamondrock Hospitality (DRH) PT Raised to $13.50 at Stifel